Get to know our new AMR Centre management committee members

Meet the new Management Committee members of the AMR Centre.

Dr Megan Carey

Megan Carey is an Infectious Diseases Epidemiologist with a focus on use of genomic epidemiology to characterise antimicrobial resistance and to inform policy. Currently, she is an Associate Director at IAVI, where she is developing a new AMR strategy, and a Policy Fellow on the AMRnet Project at the London School of Hygiene and Tropical Medicine. She am also a Coordinator of the Global Typhoid Genomics Consortium.  

Megan has a Master’s degree in Infectious Disease Epidemiology and Vaccine Science and Policy, and a Doctoral degree in the molecular epidemiology of Salmonella Typhi and its uses in informing policy. She spent over a decade working in global health research, strategy, policy and funding, and am particularly interested in cross-sectoral approaches to tackling antimicrobial resistance and promoting health equity. 


Dr James Cross

James Cross is a Research Fellow specialising in Infectious Disease Epidemiology. He co-leads the LSHTM Healthcare-Associated Infection Interest Group and is a new member of the AMR Centre Management Committee, focusing on paediatric clinical microbiology.  

His research supports neonatal inpatient healthcare in low- and middle-income countries by enhancing clinical bacteriology services, improving outbreak detection, and promoting antibiotic stewardship. This approach combines clinical microbiology and health data science to reduce neonatal infections and mortality. His implementation research spans 130 newborn units across Malawi, Tanzania, Kenya, Nigeria and Ethiopia within the NEST360 Alliance, where he also co-leads the NEST360 Infection Group.  

James holds a BSc. Hons. in Medical Microbiology from the University of Bristol and a PhD in Epidemiology & Population Health from LSHTM, conducted over five years at MRCG in The Gambia. 


Dr Rebecca Glover

Rebecca Glover, the new AMR Centre Deputy Director, is an Assistant Professor in PHP. She splits her time between co-leading the Pharmacy First Evaluation, where the team pays close attention to the impact of the programme on AMU and AMR outcomes, and the Public Health Policy Research Unit.  

She is delighted to rejoin the management committee of the AMR Centre, having previously served a term as the Head of Economic, Social, and Political Sciences. 


Dr Anton Spadar

Anton is a member of the AMR Centre Management Committee where supports Humanities and Environmental Sciences pillar focusing on different ways in which environmental surveillance can help understand epidemiology and drivers of AMR.  

His research focuses on the way data science can inform design and analysis of laboratory work. His current project is the development and validation of PCR amplicon panel for environmental surveillance of Salmonella enterica serovar Typhi. Prior to this, he investigated biomarkers of hypervirulence in Klebsiella pneumoniae and the relationship between this bacteria's carbapenemase resistance and hypervirulence phenotypes.  

In parallel,  he also continued his MSc work on Aedes mosquitoes, investigating the origin of chromosomally integrated DNA from non-retroviral RNA viruses, and creating a catalogue of possible resistance mutations in Aedes aegypti mosquitoes. In addition to this work, he is pursuing other projects including AI-assisted development of novel anti-TB drugs and application of amplicons in understanding UK tick-borne infections and management of plant pests. 


Dr Richard Wall

Richard Wall is a  Research Fellow and member of the Centre for Global Health Discovery at LSHTM.  

Richard has a background in drug discovery for tropical diseases, with a particular focus on understanding how new drugs work. This includes working on new treatments for malaria, sleeping sickness, Chagas disease, tuberculosis and leishmaniasis using a wide range of molecular and biochemical techniques. In his current role, he works closely with industrial partners to develop new drugs against Mycobacterium tuberculosis.  

Fee discounts

Our postgraduate taught courses provide health practitioners, clinicians, policy-makers, scientists and recent graduates with a world-class qualification in public and global health.

If you are coming to LSHTM to study a distance learning programme (PG Cert, PG Dip, MSc or individual modules) starting in 2024, you may be eligible for a 5% discount on your tuition fees.

These fee reduction schemes are available for a limited time only.